5. Takashima S, Armstrong D, Becker L, Bryan C. Cerebral
hypoperfusion in the sudden infant death syndrome? Brain stem
gliosis and vasculature. Ann Neurol 1978; 4: 257–62
6. Stoltenburg-Didinger HG, Kordes U. GFAP-Expression im
Hirngewebe bei SIDS. Bulletin de l'Office federal de la sante
publique 1990; 11: 135–6
7. Buck GM, Cookfair DL, Michalekt AM, Naca PC, Standfast SJ,
Sever LE. Assessment of in uteri hypoxia and risk of sudden
infant death syndrome. Paediatr and Perinat Epidemiol 1989; 3:
157–73
8. Schellscheidt J, Ott A, Jorch G. Epidemiological features of
sudden infant death after a German intervention campaign in
1992. Eur J Pediatr 1997; 156: 655–60
9. Poets CF, Schlaud M, Kleemann WJ, Rudolph A, Diekmann U,
Sens B. Sudden infant death and maternal smoking, results from
the Lower Saxony Perinatal Working Group. Eur J Pediatr 1995;
154: 326–9
10. Cnattingius S, Haglund B, Meirik O. Cigarette smoking as risk
factor for late fetal and early neonatal death. BMJ 1988; 297:
258–61
11. Milerad J, Rajs J, Gidlund E. Nicotine and conitine levels in
pericardial fluid in victims of SIDS. Acta Paediatr 1994; 83: 59–
62
12. Haglund B, Cnattingius S. Cigarette smoking a risk factor for
sudden infant death syndrome: a population-based study. Am J
Public Health 1990; 80: 29–32
13. Lambers DS, Clark KE. The maternal and fetal physiologic
effects of nicotine. Semin Perinatol 1996; 20: 115–26
14. Cole PV, Hawkins LH, Roberts D. Smoking during pregnancy
and its effect on the fetus. J Obstet Gynaecol Br Commonw
1972; 79: 782–7
15. Gilbert-Barness E, Keninson K, Carver J. Fetal haemoglobin and
sudden infant death syndrome. Arch Pathol Lab Med 1993; 117:
177–9
16. Storm H, Rognum TO, Saugstad OD, Skullerud K, Reichelt KL.
Beta-endorphin immunoreactivity in spinal fluid and hypoxanthine in vitreous humour related to brain stem gliosis in
sudden infant death syndrome. Eur J Pediatr 1994; 153: 675–81
17. Fagerli I, Hansen TW. Administration of naloxone to newborn
